Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - US
The Guardian - US
World
Melody Schreiber

US supreme court temporarily extends access to mail-order abortion medication mifepristone

A container holding boxes of Mifepristone
In 2023, the FDA ended a requirement to prescribe mifepristone in person, opening up remote dispensation via telehealth. Photograph: Evelyn Hockstein/Reuters

The US supreme court extended a short-term order to continue allowing nationwide access to mail-order mifepristone, an abortion medication, in a shadow-docket decision on Monday.

The US court of appeals for the fifth circuit in Louisiana ordered a ban on shipping mifepristone through the mail on 1 May, but Justice Samuel Alito, who responds to emergency requests from the fifth circuit, granted a temporary stay on 4 May to last until at least Monday’s decision. The emergency appeal to the court came from two mifepristone manufacturers.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.